在临床试验挑战中促进儿科和先天性心脏病学的进步
Nadia Chaudhry-Waterman1, Kristin M Burns2, Gail D Pearson2
1University of Colorado, Aurora, USA. nadiacwaterman91@gmail.com.
Pediatric cardiology
|June 13, 2025
概括
儿童心脏病专家面临的挑战是为儿童心脏病的成年幸存者提供证据. 合作研究工作对于推进临床试验管理和改善患者结果至关重要.
科学领域:
- 儿童心脏病学 儿童心脏病学
- 遗传性心脏病研究 遗传性心脏病研究
- 心脏病学中的临床试验
背景情况:
- 儿童心脏病患者的存活率增加到成年期.
- 与成人心脏病学相比,成人先天性心脏病学的证据基础有限.
- 由于疾病异质性和小患者群体,儿童心脏病学研究面临的挑战.
研究的目的:
- 审查显著的儿科心脏病学临床研究工作.
- 突出儿童心血管临床试验中的挑战.
- 强调需要在儿科心脏病研究中持续关注的领域.
主要方法:
- 审查多中心注册表和儿童心脏病学领域的合作努力.
- 讨论研究设计,终点,招聘和保留方面的挑战.
- 来自2023年心血管临床试验师 (CVCT) 论坛的见解.
主要成果:
- 在儿科心脏病学中建立多中心注册表和学习网络.
- 识别儿科心血管临床试验设计和执行的复杂性.
- 承认需要持续的研究和合作.
结论:
- 多中心合作对于推进儿科心脏病研究至关重要.
- 解决研究挑战对于改善成年先天性心脏病幸存者的长期结果至关重要.
- 需要持续专注于创新的研究策略.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


